SuperworthelectroCore profit margin ECOR
Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.
- Net margin, 12 months
- −40.0%
- Operating margin, 12 months
- −37.6%
- Net margin on a year earlier
- +7.9 pts
- Peer median
- 6.8%
Over the twelve months to Jun 30, 2026, electroCore kept −40.0% of its revenue as net profit, with an operating margin of −37.6% and a gross margin of 87.1%.
The median for 10 healthcare stocks of a similar size is 6.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −43.6% | −41.1% | 86.8% |
| FY2024 | −47.2% | −48.3% | 85.0% |
| FY2023 | n/a | n/a | 82.5% |
| FY2022 | n/a | n/a | 81.2% |
| FY2021 | n/a | n/a | 74.6% |
| FY2020 | n/a | n/a | 50.3% |
| FY2019 | n/a | n/a | 51.6% |
| FY2018 | n/a | n/a | 41.7% |
| FY2017 | n/a | n/a | 36.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −40.0% | +7.9 pts | −37.6% | |
| Q1 FY26 | −44.1% | +2.2 pts | −42.0% | |
| Q4 FY25 | −43.6% | +3.6 pts | −41.1% | |
| Q3 FY25 | −47.5% | +6.9 pts | −44.5% | |
| Q2 FY25 | −47.8% | +19.0 pts | −47.1% | |
| Q1 FY25 | −46.2% | +41.9 pts | −45.9% | |
| Q4 FY24 | −47.2% | n/a | −48.3% | |
| Q3 FY24 | −54.4% | n/a | −55.9% | |
| Q2 FY24 | −66.8% | n/a | −68.2% | |
| Q1 FY24 | −88.1% | n/a | −90.5% | |
| Q4 FY23 | n/a | n/a | n/a | |
| Q3 FY23 | n/a | n/a | n/a |
Against its peers
Companies in Healthcare nearest electroCore's size, closest first, today.
| Company | Profit margin |
|---|---|
| ECORelectroCore | −40.0% |
| SPROSpero Therapeutics | 15.7% |
| APTAlpha Pro Tech | 6.8% |
| LFVNLifevantage | 2.8% |
| ATNMActinium Pharmaceuticals | n/m |
| ICCCImmucell | 2.6% |
| KEQUKewaunee Scientific | 3.0% |
| NEPHNephros | 8.4% |
| PDEXPro DEX | 17.6% |
| PLXProtalix BioTherapeutics | 23.5% |
| NATRNatures Sunshine Products | 3.7% |
| Peer median | 6.8% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on electroCore
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.